1 Min Read
April 26 (Reuters) - Valeant Pharmaceuticals International Inc
* Bausch + Lomb receives 510(K) clearance from FDA for vitesse, the first and only hypersonic, open-port vitrectomy system Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.